Calamos Advisors’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Calamos Advisors’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,500	Closed	-$1.06K	–	1168
2023 Q1	$1.06K	Hold	12,500	–	–	﹤0.01%	1129
2022 Q4	$64	Hold	12,500	–	–	﹤0.01%	1232
2022 Q3	$1K	Buy	+12,500	New	+$2.19K	﹤0.01%	1264

Calamos Advisors's LVACW Position: Q2 2023 in Review

Calamos Advisors sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 12,500 shares — an estimated $1.06K sold.

Calamos Advisors first reported a position in LVACW in Q3 2022 and held it in 3 quarters. The position peaked at $1.06K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Calamos Advisors reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Calamos Advisors sold 12,500 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $1.06K.
Calamos Advisors first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q3 2022 and held it in 3 quarters.
Calamos Advisors's LAVA Medtech Acquisition Corp. Warrants position peaked at $1.06K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.